Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Ionis Pharmaceutical (IONS)

48.51 2.66 (5.8%)

04-20 16:00

Open:

50.44

Pre. Close:

45.85

High:

50.44

Low:

46.79

Volume:

4,477,073

Market Cap:

6085M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

50.477 - 50.716

50.716 - 50.941

Low:

46.205 - 46.468

46.468 - 46.715

Close:

48.072 - 48.491

48.491 - 48.885

Technical analysis  (as of: 2018-04-20 4:30:54 PM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 62.08     One year: 72.51

Support:

Support1: 45.23    Support2: 40.33

Resistance:

Resistance1: 53.15    Resistance2: 62.08

Pivot:

43.66

Moving Averages:

MA(5): 45.67     MA(20): 44.37

MA(100): 50.13     MA(250): 51.33

MACD:

MACD(12,26): -0.86     Signal(12,26,9): -1.59

%K %D:

%K(14,3): 82.30     %D(3): 69.14

RSI:

RSI(14): 58.52

52-Week:

High: 65.51  Low: 40.33  Change(%): 6.1

Average Vol(K):

3-Month: 111906  10-Days 134004

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
IONS has closed above the upper band by 13.6%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 11.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-04-20T09:11:52-04:00
Premarket Gainers as of 9:05 am (04/20/2018)

2018-04-20T07:10:14-04:00
Ionis up 8% premarket on new $1B 10-year collaboration with Biogen in neurological diseases

2018-04-20T06:30:00-04:00
Biogen and Ionis Expand Strategic Collaboration to Develop Drug Candidates for a Broad Range of Neurological Diseases

2018-04-20T01:06:18-04:00
Ionis: Cash, Catalysts And More

2018-04-17T12:11:00-04:00
Presentations at the 2018 American Academy of Neurology Highlight the Broad Potential of Antisense Drugs for Neurological Diseases

2018-04-17T08:17:46-04:00
J&J cost cutting plan may pressure suppliers - Bloomberg

2018-04-12T11:32:45-04:00
Akcea Undervalued As Commercial Launches Near

2018-04-11T00:31:59-04:00
Biotech Analysis Central Pharma News: Novartis's Gene Therapy Catch, AstraZeneca's NASH Move, Clovis's Expanded Rubraca Market

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

125.40

Shares Float (M)

124.88

% Held by Insiders

0.40

% Held by Institutions

Shares Short (K)

10718

Shares Short Prior Month (K)

10200

Stock Financials

EPS

-0.040

EPS Est. Current Year

-0.170

EPS Est. Next Year

0.060

EPS Est. Next Quarter

-0.090

Forward EPS

0.080

Book Value (p.s.)

16.540

PEG Ratio

-5.30

Profit Margin

-5.23

Operating Margin

4.91

Return on Assets (ttm)

0.9

Return on Equity (ttm)

4.5

Qtrly Rev. Growth

7.5

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

0.238

Qtrly Earnings Growth

-89.40

Operating Cash Flow (M)

174.15

Levered Free Cash Flow (M)

154.58

atoplab.com

Valuation

P/E

-1212.75

P/E Growth Ratio

0.06

P/BV

2.93

P/S

1487323648.00

P/CF

34.93

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.